| **FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)**                                    | 12 Months Ended |              |
|--------------------------------------------------------------------------------------------------------------------------|-----------------|--------------|
||
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Maximum contract duration (in years)                                                                                     | 2 years         |         |   |   |
| Maximum duration, interest rate contracts (in years)                                                                     | 3 years         |         |   |   |
| Cash flow hedge gain (loss) to be reclassified within twelve months                                                      | $ 22,000,000    |         |   |   |
| Derivative instruments subject to contractually defined counterparty liability position limits                           | 0               | $ 0          |   |   |
| Total                                                                                                                    | 0               | 329,000,000  | $ 0 |   |
| Goodwill impairment                                                                                                      |            | 228,000,000  |   |   |
| Senior Long-Term Notes And Debentures; 4.40%, $500 Due May                                                               |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Face value                                                                                                               | 500,000,000     |         |   |   |
| Senior Long-Term Notes And Debentures; 4.60%, $600 Due May 2032                                                          |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Face value                                                                                                               | 600,000,000     |         |   |   |
| Senior Notes                                                                                                             |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Face value                                                                                                               |            |         |   | $ 1,100,000,000,000 |
| Senior Notes | Senior Long-Term Notes And Debentures; 4.40%, $500 Due May                                                |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Face value                                                                                                               |            |         |   | 500,000,000 |
| Senior Notes | Senior Long-Term Notes And Debentures; 4.60%, $600 Due May 2032                                           |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Face value                                                                                                               |            |         |   | $ 600,000,000 |
| Health and Wellness                                                                                                      |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Total                                                                                                                    |            | 343,000,000  |   |   |
| Goodwill impairment                                                                                                      |            | 228,000,000  |   |   |
| Impairment of other assets                                                                                               |            | 22,000,000   |   |   |
| Health and Wellness | Vitamins, Minerals and Supplements                                                                 |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Total                                                                                                                    |            | 329,000,000  |   |   |
| Goodwill impairment                                                                                                      |            | 228,000,000  |   |   |
| Trademarks | Health and Wellness | Vitamins, Minerals and Supplements                                                    |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Impairment of intangible assets                                                                                          |            | 93,000,000   |   |   |
| Interest rate derivative contracts                                                                                       |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Derivative, notional amount                                                                                              | 0               | 300,000,000  |   |   |
| Derivative, notional amount, additional contracts                                                                        | 650,000,000     |         |   |   |
| Settlement of interest rate derivative contracts                                                                         | 114,000,000     |         |   |   |
| Interest rate derivative contracts | Senior Long-Term Notes And Debentures; 4.40%, $500 Due May                          |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Settlement of interest rate derivative contracts                                                                         | $ 25,000,000    |         |   |   |
| Amortization period of settlement payment (in years)                                                                     | 7 years         |         |   |   |
| Interest rate derivative contracts | Senior Long-Term Notes And Debentures; 4.60%, $600 Due May 2032                     |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Settlement of interest rate derivative contracts                                                                         | $ 89,000,000    |         |   |   |
| Amortization period of settlement payment (in years)                                                                     | 10 years        |         |   |   |
| Total Commodity Purchase Derivative Contracts                                                                            |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Maximum duration, commodity contracts (in years)                                                                         | 2 years         |         |   |   |
| Derivative, notional amount                                                                                              | $ 27,000,000    | 32,000,000   |   |   |
| Jet Fuel Swaps                                                                                                           |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Derivative, notional amount                                                                                              | 9,000,000       | 9,000,000    |   |   |
| Soybean Oil Futures                                                                                                      |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Derivative, notional amount                                                                                              | 18,000,000      | 23,000,000   |   |   |
| Soybean Oil Futures | Commodity purchase derivative contracts                                                            |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Cash margin balances amount                                                                                              | 1,000,000       | 0            |   |   |
| Purchases of Inventory | Foreign exchange derivative contracts                                                           |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Derivative, notional amount                                                                                              | 31,000,000      | $ 70,000,000 |   |   |
| Other assets | Carrying Amount | Fair Value, Inputs, Level 1 | Trust assets for nonqualified deferred compensation plans |            |         |   |   |
| **Derivative [Line Items]**                                                                                              |            |         |   |   |
| Decrease in deferred compensation plan                                                                                   | $ 17,000,000    |         |   |   |

| X                                                                                                                                                                                                                                                                                                     |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amortization period of settlement payment.
+ References
No definition available.
+ Details**Name:**clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod**Namespace Prefix:**clx_**Data Type:**xbrli:durationItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                         |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Derivative instruments subject to contractually defined counterparty liability position limits.
+ References
No definition available.
+ Details**Name:**clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits**Namespace Prefix:**clx_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**instant |
| X                                                                                                                                                                                                                                                                                  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Derivative, Notional Amount, Additional Contracts
+ References
No definition available.
+ Details**Name:**clx_DerivativeNotionalAmountAdditionalContracts**Namespace Prefix:**clx_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                        |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Increase (Decrease) Deferred Compensation Plan Assets
+ References
No definition available.
+ Details**Name:**clx_IncreaseDecreaseDeferredCompensationPlanAssets**Namespace Prefix:**clx_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228
+ Details**Name:**us-gaap_AssetImpairmentCharges**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994
+ Details**Name:**us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629Reference 5: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69C -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612Reference 6: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69B -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612
+ Details**Name:**us-gaap_DebtInstrumentFaceAmount**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**instant |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b)(1) -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959
+ Details**Name:**us-gaap_DerivativeGainLossOnDerivativeNet**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**credit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details**Name:**us-gaap_DerivativeLineItems**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Nominal or face amount used to calculate payment on derivative.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1B -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959
+ Details**Name:**us-gaap_DerivativeNotionalAmount**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**na**Period Type:**instant |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 55 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267
+ Details**Name:**us-gaap_GoodwillImpairmentLoss**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details**Name:**us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details**Name:**us-gaap_MarginDepositAssets**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**instant |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994
+ Details**Name:**us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge**Namespace Prefix:**us-gaap_**Data Type:**xbrli:durationItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994
+ Details**Name:**us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1**Namespace Prefix:**us-gaap_**Data Type:**xbrli:durationItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994
+ Details**Name:**us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1**Namespace Prefix:**us-gaap_**Data Type:**xbrli:durationItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details**Name:**us-gaap_OtherAssetImpairmentCharges**Namespace Prefix:**us-gaap_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                             |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_DebtInstrumentAxis=clx_SeniorLongTermNotesAndDebentures440500DueMay2029Member**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                             |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_DebtInstrumentAxis=clx_SeniorLongTermNotesAndDebentures460600DueMay2032Member**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                              |
|------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                         |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                        |
|----------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_SubsegmentsAxis=clx_VitaminsMineralsAndSupplementsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                        |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                               |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                                        |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**clx_CommodityPurchaseDerivativeContractsAxis=clx_JetFuelSwapsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**clx_CommodityPurchaseDerivativeContractsAxis=clx_SoybeanOilFuturesMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                            |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                  |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                                       |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                          |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                                |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_InvestmentTypeAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |